SH
Stephen Hoge sold $16.9M of MRNA stock
Stephen Hoge, President of Moderna, Inc. (MRNA), sold 78,375 shares of MRNA stock worth $16.9M, per an SEC Form 4 filed Nov 18, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Nov 16, 2026, 2 days before it was made public.
MRNA has moved -7.4% since the trade date, from $215.27 to $199.33 (Nov 19, 2026 close).
- Traded
- Nov 16, 2026
- Disclosed
- Nov 18, 2026
- Filing delay
- 2 days
- Price since
- -7.4%
- Role
- President
- Source
- SEC Form 4